- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on CEA-expressing Non Small Cell Lung Carcinoma (NSCLC)
Total 6924 results
-
Kai-Uwe Schmitt, PhD, MEng, ICIDRecruitingNon-Small Cell Lung Cancer (NSCLC)Switzerland
-
PfizerCompletedNSCLC (Non-small Cell Lung Cancer)Hong Kong, China, Taiwan, Malaysia, Thailand
-
National Taiwan University HospitalUnknownNon-small Cell Lung Cancer(NSCLC)Taiwan
-
Incyte CorporationWithdrawnSolid Tumors and Hematologic Malignancy | NSCLC (Non-small Cell Lung Carcinoma)United States
-
Elevation OncologyMerrimack PharmaceuticalsTerminatedAdenocarcinoma | Non-Small Cell Lung Cancer | NSCLC | HeregulinSpain, Canada, United States, Germany, Hungary, France
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Bristol-Myers SquibbCompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage I Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma | Non-Squamous Non-Small...United States
-
National Cancer Institute (NCI)RecruitingAdenocarcinoma | Advanced Non-Small Cell Lung Cancer | Squamous Cell Carcinoma | Advanced NSCLC | Adenosquamous CarcinomaUnited States
-
TakedaRecruitingNon-small Cell Lung Cancer (NSCLC)China
-
PfizerRecruitingNSCLC | Non-Small-Cell Lung CancerSpain, Taiwan, France, China, Singapore, Japan, United States
-
First People's Hospital of HangzhouHangzhou Cancer HospitalRecruitingNon Small Cell Lung Cancer | EGFR Activating Mutation | Stage III NSCLCChina
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Active, not recruitingNon-Small-Cell-Lung Cancer (NSCLC)United States
-
Second Affiliated Hospital, School of Medicine,...RecruitingNSCLC | Neoadjuvant TherapyChina
-
University Hospital, Strasbourg, FranceRecruitingNSCLC | IMMUNOTHERAPY | QUANTIFICATION OF CELL-FREE DNAFrance
-
Goethe UniversityRecruitingNSCLC Stage IV | NSCLC Stage IIIBGermany
-
Shanghai Pharmaceuticals Holding Co., LtdWithdrawn
-
Beijing Chest HospitalUnknown
-
Suzhou Junjing BioSciences Co., Ltd.Sponsor GmbHRecruitingLocally Advanced or Metastatic NSCLCChina
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaActive, not recruitingAdvanced or Metastatic NSCLCUnited States, Spain, Taiwan, Japan, Italy
-
The Fourth Affiliated Hospital of Zhejiang University...CompletedNSCLC | EGFR Gene Mutation | Non-small-lung-cell CancerChina
-
Beta Pharma ShanghaiActive, not recruiting
-
Armando Santoro, MDTerminated
-
Allist Pharmaceuticals, Inc.UnknownAdvanced NSCLC Patients With T790MChina
-
Shanghai JMT-Bio Inc.Not yet recruiting
-
Shanghai Zhongshan HospitalNot yet recruiting
-
AkesoNot yet recruitingLocally Advanced or Metastatic NSCLCChina
-
Guangdong Provincial People's HospitalRecruiting
-
National Taiwan University HospitalActive, not recruiting
-
Second Affiliated Hospital, School of Medicine,...Completed
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.UnknownLocally Advanced or Metastatic NSCLCChina
-
International Group of Endovascular OncologyAzienda Sanitaria OspedalieraUnknownLocally Advanced/ Metastatic NSCLCItaly
-
Peking Union Medical College HospitalUnknown
-
Shanghai Kechow Pharma, Inc.Terminated
-
Instituto Oncológico Dr RosellTurning Point Therapeutics, Inc.Recruiting
-
PTS International Inc.Completed
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
Jun Zhang, MD, PhDUniversity of Iowa; University of KentuckyRecruitingNSCLC Stage IV | NSCLC Stage IIIBUnited States
-
Addario Lung Cancer Medical InstituteBiodesix, Inc.TerminatedNSCLC Stage IV | NSCLC, Stage IIICUnited States
-
Swiss Group for Clinical Cancer ResearchActive, not recruiting
-
National Cancer Center, KoreaHoffmann-La RocheActive, not recruitingNSCLC Stage II | NSCLC, Stage IIIAKorea, Republic of
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.RecruitingHase 1/2 Study of HS-10375 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)Advanced or Metastatic NSCLCChina
-
AstraZenecaDaiichi SankyoRecruitingAdvanced or Metastatic NSCLCUnited States, Taiwan, Italy, Spain, Poland, Japan, Belgium, Turkey, France, Korea, Republic of
-
AstraZenecaActive, not recruitingAdvanced or Metastatic NSCLCRussian Federation
-
Technical University of MunichCompleted
-
InventisBio Co., LtdCompletedNSCLC | Solid Tumor | EGFR T790MChina
-
Beta Pharma ShanghaiCompleted
-
Jiangsu Healthy Life Innovation Medical Technology...Not yet recruitingNon-small Cell Lung Cancer (NSCLC)China
-
Massachusetts General HospitalRecruitingNon-Small Cell Lung Cancer (NSCLC)United States
-
Massachusetts General HospitalGenentech, Inc.UnknownNon-Small Cell Lung Cancer (NSCLC)United States
-
Concordia Laboratories Inc.CompletedNon-small Cell Lung Cancer (NSCLC) | Lung MetastasisUnited States, Canada
-
Turning Point Therapeutics, Inc.TerminatedNon-Small Cell Lung Cancer | NSCLC | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | ALK Gene MutationUnited States, Australia, Korea, Republic of